These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7026905)

  • 1. Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia.-I. Velocity sedimentation.
    Hagenbeek A; Martens AC; van Bekkum DW
    Leuk Res; 1981; 5(4-5):421-8. PubMed ID: 7026905
    [No Abstract]   [Full Text] [Related]  

  • 2. The proliferative state of normal hemopoietic stem cells during progression of leukemia. Studies in the BN acute myelocytic leukemia (BNML).
    Hagenbeek A; Martens AC
    Leuk Res; 1981; 5(2):141-8. PubMed ID: 6941052
    [No Abstract]   [Full Text] [Related]  

  • 3. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A; Martens AC
    Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia. II. Velocity sedimentation in combination with density gradient separation.
    Hagenbeek A; Martens AC
    Exp Hematol; 1981 Jul; 9(6):573-80. PubMed ID: 6943036
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathogenesis of a rat model for human acute myelocytic leukemia.
    Hagenbeek A; Martens AC
    Haematologica; 1980 Jun; 65(3):293-308. PubMed ID: 6778781
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia.
    van Bekkum DW; van Oosterom P; Dicke KA
    Cancer Res; 1976 Mar; 36(3):941-6. PubMed ID: 1062232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tritiated thymidine labeling and suicide indices in acute nonlymphocytic leukemia.
    Preisler H; Shoham D
    Cancer Res; 1978 Nov; 38(11 Pt 1):3681-4. PubMed ID: 279395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway 'leukemic stem cell line'.
    Lacaze N; Gombaud-Saintonge G; Lanotte M
    Leuk Res; 1983; 7(2):145-54. PubMed ID: 6574296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
    Martens AC; Hagenbeek A
    Cytometry; 1985 Jul; 6(4):342-7. PubMed ID: 3860369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro separation of bone marrow nuclear cells with methylcellulose and its application to autologous bone marrow transplantation in patients with leukemia].
    Bai H; Da WM; Dong GP
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):103-5. PubMed ID: 8070289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the distribution pattern of Brown Norway myeloid leukaemia cells and L4415 lymphatic leukaemia cells in rat femoral bone marrow after i.v. infusion.
    Prins ME; van Bekkum DW
    Leuk Res; 1981; 5(1):57-63. PubMed ID: 6939951
    [No Abstract]   [Full Text] [Related]  

  • 13. On the heterogeneity of minimal residual disease in acute leukemia.
    Hagenbeek A; Martens AC
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():9-12. PubMed ID: 2713565
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
    el-Beltagi HM; Martens AC; Lelieveld P; Haroun EA; Hagenbeek A
    Cancer Res; 1993 Jul; 53(13):3008-14. PubMed ID: 8319208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrow.
    Douay L
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):427-36. PubMed ID: 3912921
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of AML cells and normal hemopoietic cells: replacement or inhibition?
    van Bekkum DW; van Oosterom PM
    Bibl Haematol; 1975 Oct; (43):10-2. PubMed ID: 1067083
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro study of bone marrow from leukemic patients and subjects with no hematologic disorders].
    Varga G; Bordényi Z; Krizsa F; Cserháti I
    Orv Hetil; 1984 Feb; 125(9):505-8. PubMed ID: 6366695
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth pattern of a transplantable acute myeloid leukemia in the rat.
    Foa P
    Eur J Cancer (1965); 1981 Feb; 17(2):211-6. PubMed ID: 6943027
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth and differentiation of normal and leukemic human bone marrow cells cultured in diffusion chambers.
    Steele AA; Sensenbrenner LL; Young MG
    Exp Hematol; 1977 May; 5(3):199-210. PubMed ID: 326572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.